These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Next-generation sequencing for tumor mutation quantification using liquid biopsies. Provencio M; Pérez-Barrios C; Barquin M; Calvo V; Franco F; Sánchez E; Sánchez R; Marsden D; Cristóbal Sánchez J; Martin Acosta P; Laza-Briviesca R; Cruz-Bermúdez A; Romero A Clin Chem Lab Med; 2020 Jan; 58(2):306-313. PubMed ID: 31469650 [TBL] [Abstract][Full Text] [Related]
3. Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy. Allegretti M; Cottone G; Carboni F; Cotroneo E; Casini B; Giordani E; Amoreo CA; Buglioni S; Diodoro M; Pescarmona E; Zazza S; Federici O; Zeuli M; Conti L; Cigliana G; Fiorentino F; Valle M; Giacomini P; Spinella F J Exp Clin Cancer Res; 2020 Apr; 39(1):69. PubMed ID: 32312295 [TBL] [Abstract][Full Text] [Related]
4. Toward liquid biopsies in cancer treatment: application of circulating tumor DNA. Barlebo Ahlborn L; Østrup O APMIS; 2019 May; 127(5):329-336. PubMed ID: 30784124 [TBL] [Abstract][Full Text] [Related]
5. Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies. Coccaro N; Tota G; Anelli L; Zagaria A; Specchia G; Albano F Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365599 [TBL] [Abstract][Full Text] [Related]
6. Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations. Iwama E; Sakai K; Azuma K; Harada T; Harada D; Nosaki K; Hotta K; Ohyanagi F; Kurata T; Fukuhara T; Akamatsu H; Goto K; Shimose T; Kishimoto J; Nakanishi Y; Nishio K; Okamoto I Ann Oncol; 2017 Jan; 28(1):136-141. PubMed ID: 28177428 [TBL] [Abstract][Full Text] [Related]
7. Droplet-Based Digital PCR: Application in Cancer Research. Perkins G; Lu H; Garlan F; Taly V Adv Clin Chem; 2017; 79():43-91. PubMed ID: 28212714 [TBL] [Abstract][Full Text] [Related]
8. Detection of circulating tumor DNA (ctDNA) by digital droplet polymerase chain reaction (dd-PCR) in liquid biopsies. Valpione S; Campana L Methods Enzymol; 2019; 629():1-15. PubMed ID: 31727235 [TBL] [Abstract][Full Text] [Related]
9. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141 [TBL] [Abstract][Full Text] [Related]
10. Emerging digital PCR technology in precision medicine. Zhang L; Parvin R; Fan Q; Ye F Biosens Bioelectron; 2022 Sep; 211():114344. PubMed ID: 35598553 [TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy: unlocking the potentials of cell-free DNA. Chu D; Park BH Virchows Arch; 2017 Aug; 471(2):147-154. PubMed ID: 28466157 [TBL] [Abstract][Full Text] [Related]
12. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine. Moldogazieva NT; Zavadskiy SP; Terentiev AA Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362 [TBL] [Abstract][Full Text] [Related]
14. Applications of Digital Polymerase Chain Reaction (dPCR) in Molecular and Clinical Testing. Wainman LM; Sathyanarayana SH; Lefferts JA J Appl Lab Med; 2024 Jan; 9(1):124-137. PubMed ID: 38167753 [TBL] [Abstract][Full Text] [Related]
15. The Role of BEAMing and Digital PCR for Multiplexed Analysis in Molecular Oncology in the Era of Next-Generation Sequencing. Denis JA; Guillerm E; Coulet F; Larsen AK; Lacorte JM Mol Diagn Ther; 2017 Dec; 21(6):587-600. PubMed ID: 28667577 [TBL] [Abstract][Full Text] [Related]
16. Validation of the digital PCR system in tyrosine kinase inhibitor-resistant EGFR mutant non-small-cell lung cancer. Masago K; Fujita S; Hata A; Okuda C; Yoshizumi Y; Kaji R; Katakami N; Hirata Y; Yatabe Y Pathol Int; 2018 Mar; 68(3):167-173. PubMed ID: 29341374 [TBL] [Abstract][Full Text] [Related]
17. Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective. Postel M; Roosen A; Laurent-Puig P; Taly V; Wang-Renault SF Expert Rev Mol Diagn; 2018 Jan; 18(1):7-17. PubMed ID: 29115895 [TBL] [Abstract][Full Text] [Related]
18. Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas. Hickmann AK; Frick M; Hadaschik D; Battke F; Bittl M; Ganslandt O; Biskup S; Döcker D BMC Cancer; 2019 Mar; 19(1):192. PubMed ID: 30823914 [TBL] [Abstract][Full Text] [Related]
19. The Emerging Role of Liquid Biopsies in Revolutionising Cancer Diagnosis and Therapy. Shegekar T; Vodithala S; Juganavar A Cureus; 2023 Aug; 15(8):e43650. PubMed ID: 37719630 [TBL] [Abstract][Full Text] [Related]
20. Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia Patients. Alikian M; Ellery P; Forbes M; Gerrard G; Kasperaviciute D; Sosinsky A; Mueller M; Whale AS; Milojkovic D; Apperley J; Huggett JF; Foroni L; Reid AG J Mol Diagn; 2016 Mar; 18(2):176-89. PubMed ID: 26857065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]